BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11367341)

  • 1. False-negative Pap test rate high.
    Newsline People AIDS Coalit N Y; 1999; ():31. PubMed ID: 11367341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The danger of only using a Pap smear.
    Vazquez E
    Posit Aware; 1999; 10(3):23. PubMed ID: 11366762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annual colposcopies and pap smears recommended for women with HIV.
    Highleyman L
    BETA; 1999 Apr; 12(2):6. PubMed ID: 11366700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of colposcopy in evaluation of the cervix for unexpectedly positive pap smears].
    Jesień-Sokołowska U; Madej JG
    Przegl Lek; 1999; 56(1):17-9. PubMed ID: 10375918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening issues for HIV positive women: a physician's perspective.
    Bardaro L
    BETA; 1996 Jun; ():35-8. PubMed ID: 11363648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of HIV infection on atypical squamous cells of undetermined significance.
    Duerr A; Paramsothy P; Jamieson DJ; Heilig CM; Klein RS; Cu-Uvin S; Schuman P; Anderson JR;
    Clin Infect Dis; 2006 Mar; 42(6):855-61. PubMed ID: 16477565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned?
    Perkins RB; Langrish SM; Stern LJ; Figueroa J; Simon CJ
    Trop Med Int Health; 2007 Sep; 12(9):1018-25. PubMed ID: 17875013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
    Zhao C; Austin RM
    Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Knowledge and use of Pap-smear among HIV-positive women].
    Pavia C; Navarra A; Pisani G; Piselli P; Koehler B; Angeletti C; Ippolito G; Serraino D
    Minerva Ginecol; 2006 Jun; 58(3):233-8. PubMed ID: 16783295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of cervical neoplasia by using pap smear with speculoscopy compared with pap smear alone.
    Boonlikit S; Supakarapongkul W; Preuksaritanond N; Vipupinyo C; Tuipae S; Mangclaviras S; Karnplumjid S; Chantarawiroj P
    J Med Assoc Thai; 2005 Feb; 88(2):138-44. PubMed ID: 15962661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeat Pap smear at the time of initial colposcopy--another view.
    Korman J
    Gynecol Oncol; 1998 Jun; 69(3):269-70. PubMed ID: 9648601
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
    Sarian LO; Derchain SF; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
    J Med Screen; 2005; 12(3):142-9. PubMed ID: 16156945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved cervical cancer screening in premenopausal women by combination of Pap smear and speculoscopy.
    Twu NF; Chen YJ; Wang PH; Yu BK; Lai CR; Chao KC; Yuan CC; Yen MS
    Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):114-8. PubMed ID: 16797826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Squamous cervical lesions in women with human immunodeficiency virus: long-term follow-up.
    Massad LS; Seaberg EC; Wright RL; Darragh T; Lee YC; Colie C; Burk R; Strickler HD; Watts DH
    Obstet Gynecol; 2008 Jun; 111(6):1388-93. PubMed ID: 18515523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus absence predicts normal cervical histopathologic findings with abnormal papanicolaou smears: a study of a university-based inner city population.
    Khanna N; Brooks SE; Chen TT; Simsir A; Gordon NJ; Taylor G
    J Hum Virol; 2001; 4(5):283-7. PubMed ID: 11907386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical screening in HIV-positive women: characteristics of those who default and attitudes towards screening.
    Shah S; Montgomery H; Smith C; Madge S; Walker P; Evans H; Johnson M; Sabin C
    HIV Med; 2006 Jan; 7(1):46-52. PubMed ID: 16313292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal dysplastic lesions in women with hysterectomy and receiving radiotherapy are linked to high-risk human papillomavirus.
    Barzon L; Pizzighella S; Corti L; Mengoli C; Palù G
    J Med Virol; 2002 Jul; 67(3):401-5. PubMed ID: 12116034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Schuman P; Ohmit SE; Klein RS; Duerr A; Cu-Uvin S; Jamieson DJ; Anderson J; Shah KV;
    J Infect Dis; 2003 Jul; 188(1):128-36. PubMed ID: 12825181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.